Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Invivoscribe
San Diego, California, United Statesinvivoscribe.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Invivoscribe provides commercial diagnostic products and services for oncology testing, with a focus on hematologic malignancies. Their recent study suggests a critical link between residual FLT3-ITD mutations in remission and post-transplant outcomes in AML.
- Therapeutic areas
- Oncology
- Modalities
- Molecular diagnostic assaysNGS gene panelsPCR-based tests
- Industry
- Molecular Diagnostics
02
Partnerships
Global pharmaceutical companies for companion diagnostics development
Beyond the preview
Go deeper on Invivoscribe.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Invivoscribe.